Table 10. Medicare ESRD program incidence and percent distribution, by diagnosis and sex: 1980.
| Diagnosis | Male | Female | Male | Female |
|---|---|---|---|---|
|
| ||||
| Incidence per million | Percent distribution | |||
| All causes | 95 | 70 | 100 | 100 |
| Glomerulonephritis | 20 | 12 | 21.5 | 17.3 |
| Primary hypertensive disease | 24 | 15 | 24.9 | 21.4 |
| Diabetic nephropathy | 19 | 17 | 20.1 | 24.1 |
| Polycystic kidney disease | 5 | 5 | 5.2 | 6.8 |
| Collagen vascular disease | ( 1) | 2 | 0.5 | 2.5 |
| Interstitial nephritis, hereditary | 1 | 1 | 1.1 | 0.8 |
| Interstitial nephritis, other | 5 | 6 | 4.8 | 8.4 |
| Analgesic abuse nephropathy | 1 | 1 | 0.6 | 1.6 |
| Obstructive uropathy, acquired | 3 | 1 | 3.5 | 1.1 |
| Obstructive uropathy, congenital | 1 | ( 1) | 1.5 | 0.7 |
| Amyloidosis | ( 1) | ( 1) | 0.5 | 0.6 |
| Multiple myeloma | 1 | 1 | 1.1 | 0.9 |
| Gouty nephropathy | 1 | ( 1) | 0.6 | 0.3 |
| Other, unspecified | 5 | 4 | 5.1 | 5.0 |
| Etiology unknown | 9 | 6 | 9.0 | 8.5 |
1
Less than 1 per million.